What to Expect in October's Editor-in-Chief Letter
Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, editor-in-chief of Contagion®, previews his editor-in-chief letter for the October 2019 issue.
Segment Description: Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, clinical professor at Temple University College of Pharmacy and editor-in-chief of Contagion®, previews his editor-in-chief letter for the October issue.
Interview transcript: (modified slightly for readability)
Dr. Gallagher: In the October Editor-in-Chief letter of Contagion®, I write about how patients do not understand what antimicrobial resistance is and really how far away we are from understanding how poor their understanding is. Truthfully practitioners are part of the problem. Sometimes our use of casual language that tries to help patients understand it may actually hurt. So just the term antibiotic resistance in 1 study, actually multiple studies I should say, over 70% of patients believe that it means the human body has become resistant to the effects of the antibiotic. And that's just 1 example of the many ways that patients misunderstand antibiotics and antibiotic resistance that we need to address and think about as we discuss with them the utility of these agents.
